在ETF市场突破6万亿之际，各家公募基金公司也是"八仙过海，各显神通"。想要在这波行情中逐步扩大自己的规模。此前我们在《规模剑指6万亿，年内资 金疯狂抢筹！ETF才是版本T0》一文中，曾指出年初至今规模涨幅前10名中有一半是宽基"选手"。其中华泰柏瑞沪深300ETF、华夏沪深300ETF、易方达沪 深300ETF、嘉实沪深300ETF这四大天王涨幅明显，而代表新兴市场的中证A500在在后半程发力。 由此可见，宽基的"风头"当前依旧无人可比，而此类策略也成了各大基金公司的"兵家必争之地"。新时空研究院整理发现：岁末年初，华泰柏瑞、汇添富、 易方达等头部公募持续以"一指多发"策略扩张版图：先以核心ETF迅速做大规模，形成品牌效应；再循市场节奏梯次布局联接、指数增强、LOF等多品类， 完成同一标的指数的全形态覆盖，抢占先发份额。 "一鱼多吃"现象频现，宽基策略成为主要阵地 以中证A500为例，自2024年以来，布局中证A500指数的基金管理人已近80家，相关产品已经超过280支。截至2026年1月7日，华泰柏瑞中证A500ETF规模突 破500亿元，稳居同标的基金首位。 跟踪A500的产品已达285支 数据来源：同 ...

Core Viewpoint - The Hang Seng Hong Kong Stock Connect Innovative Drug Index has seen a 0.3% increase, with significant gains in individual stocks, reflecting a positive trend in the innovative pharmaceutical sector driven by government policies and increasing demand for new drugs [1] Group 1: Market Performance - The Hang Seng Hong Kong Stock Connect Innovative Drug Index rose by 0.3% [1] - Notable stock performances include BGI Genomics rising over 7%, Tonghua Dongbao Pharmaceutical increasing over 4%, and Innovent Biologics up over 2% [1] - The trading volume for the Hong Kong Stock Connect Innovative Drug ETF, E Fund (159316), reached approximately 500 million yuan [1] Group 2: Government Policy - The "Guangzhou Plan for Accelerating the Construction of a Strong Advanced Manufacturing City (2024-2035)" was recently issued, emphasizing the acceleration of innovative drug strategic layout [1] - The plan focuses on the development of monoclonal antibodies, vaccines, blood products, and diagnostic reagents in the biopharmaceutical sector [1] - Other cities such as Beijing, Shanghai, Chongqing, and Xi'an have also introduced policies to promote high-quality development in the innovative drug industry [1] Group 3: Industry Outlook - Huachuang Securities believes that the pharmaceutical industry is reaching new heights due to the continuous demand for medical solutions and unmet needs [1] - Pharmaceutical companies are increasingly investing in research and development to meet these demands [1] - China has become a significant player in global innovative drug research and development, with a continuous rise in overseas licensing activity [1] - The industry is entering a revenue era driven by innovation [1] Group 4: Investment Opportunities - The Hang Seng Hong Kong Stock Connect Innovative Drug Index is the first index with a "purity" of 100% focused on innovative drugs, targeting leading companies in the Hong Kong stock market [1] - The E Fund (159316) is currently the only product tracking this index, providing investors with a streamlined way to capitalize on investment opportunities in this sector [1]

Group 1 - The core index of the National Certificate Robot Industry rose by 1.7%, with notable increases in component stocks such as Hongxun Technology reaching the daily limit, Aerospace Zhizhuang rising over 9%, and Haozhi Electromechanical increasing over 6% [1] - The robot ETF E Fund (159530) saw a trading volume exceeding 900 million yuan and net subscriptions surpassing 80 million shares, indicating strong market interest [1] - According to Omdia, ZhiYuan Robotics is projected to ship over 5,168 humanoid robots by 2025, capturing 39% of the global market share, making it the leader in both shipment volume and market share [1] Group 2 - Omdia categorizes ZhiYuan, Yushu, and Tesla among the "first tier" humanoid robot developers, with expectations of exponential growth in global humanoid robot shipments to 2.6 million units by 2035 [1] - The industry is experiencing significant growth driven by policy support and market enthusiasm, with related index products gaining attention for investment opportunities [1] - The National Certificate Robot Industry Index focuses on humanoid robot bodies and core components, covering companies like Sanhua Intelligent Control and Lingyi Technology, which together account for approximately 80% of the index [1]

Group 1 - The core viewpoint of the article highlights the performance of dividend assets in the early trading of January, with the CSI Dividend Value Index declining by 0.3% and certain stocks like COFCO Sugar and China Coal Energy rising over 2% [1] - Analysts suggest that the market liquidity is typically abundant at the beginning of the year, and the first quarter is a critical period for policy negotiations, which may lead to increased trading activity due to rising optimistic expectations [1] - Historical data indicates that the calendar effect of dividend style from January to March is significantly pronounced throughout the year, with dividend assets showing a certain success rate in both absolute and relative returns [1] Group 2 - E Fund's dividend value ETF (563700) recently announced its first dividend distribution, where investors will receive 0.1 yuan for every 10 fund shares held, with the record date on January 13, ex-dividend date on January 14, and cash dividend payment date on January 19 [1] - The ETF tracks the CSI Dividend Value Index, which consists of 50 stocks characterized by high dividend yields and value traits, reflecting the overall performance of stocks with high dividend levels and prominent value characteristics [1] - The banking, construction decoration, and transportation sectors collectively account for over 70% of the index, which currently has a dividend yield of 4.8% [1]

Group 1 - The A500ETF E Fund (159361) has shown strong market performance, with the index reaching above 4100 points and a trading volume of 5.56 billion yuan on January 9, 2026 [1] - Over the past 21 trading days, the A500ETF has attracted a total of 9.347 billion yuan in investments, indicating high market interest and liquidity [1] - The A500ETF closely tracks the CSI A500 Index, which consists of 500 securities selected for their large market capitalization and good liquidity, reflecting the overall performance of representative companies across various industries [1] Group 2 - Foreign institutions express strong confidence in China's economic resilience and market potential, with Goldman Sachs predicting a 20% increase in the MSCI China Index and a 12% increase in the CSI 300 Index by 2026 [2] - UBS forecasts a 14% or higher earnings growth for the MSCI China Index in 2026, driven by sectors such as internet platforms, high-end manufacturing, and companies with global expansion capabilities [2] - Standard Chartered Bank maintains an overweight position on Chinese stocks, anticipating that targeted policy stimulus and strong earnings growth related to artificial intelligence will provide robust support for the Chinese economy [2]

Group 1 - The ChiNext Mid-Cap 200 Index increased by 1.0% at midday close [1] - The ChiNext Growth Index rose by 0.2% [1] - The ChiNext Index saw a slight increase of 0.1% [1] Group 2 - The trading volume of related ETFs was active, with the E Fund ChiNext ETF (159915) achieving a half-day transaction amount of approximately 3.4 billion yuan, nearing the total volume of the previous day [1]

Group 1 - The core viewpoint of the article indicates that the technology sector is expected to lead the market recovery, with a potential "Bull Market 2.0" emerging as the "policy bottom, market bottom, and economic bottom" are validated by 2026 [1] - The ChiNext Growth Index rose by 1.2%, the ChiNext 100 Index increased by 0.9%, the ChiNext Composite Index went up by 0.6%, and the ChiNext 50 Index saw a slight rise of 0.1% at the midday close [1] - The report from Shenwan Hongyuan Securities suggests that the upcoming bull market will primarily be driven by technology and the enhancement of China's global influence, with potential for a small rebound in tech growth before spring 2026 [1]

Market Overview - The Shanghai Composite Index has broken through 4100 points for the first time in 10 years, with the CSI A500 Index rising by 0.41% [1] - AI application concepts and commercial aerospace concepts are showing strong performance, while brain-computer interface concepts have declined [1] ETF Performance - Several ETFs tracking the CSI A500 Index have seen significant trading volumes, with 12 ETFs exceeding 100 million yuan in trading volume, and 2 surpassing 10 billion yuan [1] - The A500 ETF from Huatai-PB and the A500 ETF Fund recorded trading volumes of 12.254 billion yuan and 10.443 billion yuan respectively [2] Market Drivers - Analysts indicate that the main factors supporting the market since January remain intact, including the increasing attractiveness of RMB assets and expectations for credit issuance and subsequent policies [1] - The earnings structure of enterprises has positively changed, with new economic forces represented by advanced manufacturing and overseas enterprises driving the stabilization and recovery of A-share returns, providing solid fundamental support for the market [1]

Group 1 - The A-share market indices collectively rose, with the Shanghai Composite Index increasing by 0.5% and surpassing 4100 points for the first time in 10 years, reflecting a gain of over 7% since mid-December last year and an increase of over 130 points since the beginning of the year [1] - The CSI A500 Index rose by 0.7%, while the ChiNext Index increased by 0.3%, indicating positive market sentiment [1] - The A500 ETF (E Fund, 159361) and ChiNext ETF (E Fund, 159915) both saw trading volumes exceed 1 billion yuan, highlighting strong investor interest [1] Group 2 - Industrial analysis from Industrial Securities suggests that the current market optimism is driven by confidence in the rise of major economies and structural economic transformation, supported by positive statements in the "14th Five-Year Plan" regarding policy direction and high-quality transformation [1] - The CSI A500 Index consists of 500 stocks with large market capitalization and good liquidity, covering 89 out of 93 sub-industries, effectively representing various sectors of the A-share market [1] - The ChiNext Index is composed of 100 stocks from the ChiNext board with large market capitalization and good liquidity, with over 90% of its components belonging to strategic emerging industries [1]

Core Viewpoint - Satellite concept stocks have shown strong performance in early trading, with notable increases in share prices for companies such as Aerospace Electronics, Zhenlei Technology, and China Satcom, indicating a growing interest in the satellite industry [1] Group 1: Stock Performance - Aerospace Electronics rose over 9%, Zhenlei Technology increased over 7%, and China Satcom gained over 4% [1] - Satellite-related ETFs also experienced gains, with an overall increase of over 2% [1] Group 2: ETF Details - The following satellite ETFs reported their current prices and percentage changes: - E Fund Satellite ETF: 1.703, up 2.78% [2] - Penghua Satellite ETF: 1.289, up 2.71% [2] - Satellite Industry ETF: 2.081, up 2.61% [2] - Satellite ETF: 1.711, up 2.52% [2] - GF Satellite ETF: 1.711, up 2.46% [2] Group 3: Industry Insights - Analysts suggest that China is at a pivotal moment similar to SpaceX's network development phase from 2018 to 2020, with significant satellite launches expected soon [1] - The transition from custom satellite manufacturing to a more standardized production process akin to automotive assembly lines is underway, particularly for companies providing universal power, communication, and attitude control systems [1]